Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Expanding the armamentarium for the spondyloarthropathies

Paul M Peloso and Jürgen Braun*

Arthritis Res Ther 2004, 6(Suppl 2):S36-S43 doi:10.1186/ar1012

Accesses  

  • Last 30 days: 51 accesses
  • Last 365 days: 533 accesses
  • All time: 5613 accesses